Approaches to V(D)J Sequencing
On-demand
Matt Knight, PhD
Dr. Matthew Knight has 10 years of research experience in immunology and infectious disease. At Adaptive, he focuses on helping academic customers to incorporate immunosequencing into their basic and clinical research. He specializes in experimental design, data analysis, and data interpretation.
Close
Nathan Polaske, PhD
Dr. Nate Polaske is an organic chemist with 15 years of research and development experience in cancer diagnostics and therapeutics. At Adaptive, he works closely with academic customers, providing technical support and training across Adaptive's research product portfolio.
Close
In this webinar, you will discover:
- the evolution of V(D)J and CDR3 sequencing approaches and differences in the technologies used for V(D)J sequencing;
- an overview of the current capabilities of large-scale immunosequencing of T- and B-cell receptors;
- the principles and applications of Adaptive Biotechnologies' quantitative immunoSEQ® Technology and how it can address questions across a wide variety of research topics.
Immunosequencing, the science of profiling T-cell receptors (TCRs) and B-cell receptors (BCRs), has been widely used to understand how the immune system changes during disease and how various treatment modalities impact immune responses.
Various V(D)J sequencing technologies have been used throughout the past few decades to profile the adaptive immune system.
This webinar aims to provide an overview of those different approaches, how they have evolved, and describe Adaptive Biotechnologies’ immunoSEQ Technology and its utility for profiling large and diverse repertoires.
For Research Use Only. Not for use in diagnostic procedures.
All emails contain an unsubscribe link.You can review our privacy policy, cookie policy and terms and conditions online.
